All the usual good stuff in there. Vitiligo to complete and...

All the usual good stuff in there. Vitiligo to complete and results next year and that exciting potential figure again of $490 - $570 Million USD in years 1-2. A lot of near term growth just for EPP, eg dosage expansion for adults EMA, children EMA re -file, Canada decision, US treatment centre growth etc. Also the big "will become a household name" statement. Also $20 Million for a 12 month share buyback. Just do the bloody buyback, it will make a real difference for shareholders by buying and deleting 1.5 Million CUV shares when there are only 50 Million on issue. We can all see how just a relatively small amount of buying has changed the share price to benefit shareholders. The weird thing is they could have completed the entire share buyback for just $15 Million or $16 Million in recent months when it was getting massively manipulated by shorters. Either way just do the buyback and stop just talking about it while awarding shares to yourselves - there will never be an acquisition as good as Clinuvel are now: ie printing cash at growing rates, $200 Million cash growing all the time, blockbuster phase 3 about to complete with already FDA approved drug, proven growth, proven low cost distribution network and mega cosmetic opportunities with a unique and real tanning photocosmetic they have announced in Bulletin 2.

All IMO DYOR